Havlin K A, Inglot A D, Willson J K, Borden E C, Grossberg S, Szulc B, Gladysz A, Groehlich B
University of Wisconsin Clinical Cancer Center, Madison 53792.
J Interferon Res. 1988 Apr;8(2):135-6. doi: 10.1089/jir.1988.8.135.
Dipyridamole, previously reported to be an interferon (IFN) inducer in mice, was evaluated in 43 normal volunteers or cancer patients. At doses ranging from 150 mg orally to 887 mg intravenously, no serum antiviral activity suggesting IFN induction was observed.
双嘧达莫，先前报道在小鼠中是一种干扰素（IFN）诱导剂，在43名正常志愿者或癌症患者中进行了评估。口服剂量从150毫克到静脉注射887毫克，均未观察到提示IFN诱导的血清抗病毒活性。
